HoneyLab, a New Zealand-based and operated pharmaceutical company, has today announced that it has successfully raised the capital required to fund further clinical trials on several promising products for conditions including skin diseases, diabetes, emphysema and arthritis. In addition, it has added expertise to its management by appointing to its Board the Chair of both … Continue reading NZ Pharmaceutical Company HoneyLab Obtains Investment, Expertise and Exciting Research Results